Hitomi Hosoya - Concepedia

Author

Hitomi Hosoya

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

H Hosoya, H. Hosoya, Hitomi Hosoya

104

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Stanford University Moffitt Cancer Center Harvard University Cleveland Clinic

About

Hitomi Hosoya is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	523
2	Cell Biology	3	3	434
3	Engineering	2	2	313
4	Public Health	1	1	16
5	Biomedical Engineering	1	1	43

Hitomi Hosoya

Publications

Citations

H-Index

Page 1

	Year	Citations
PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA <i>PCA3</i> Ahmad Salameh, Alessandro K. Lee, Marina Cardó‐Vila, Proceedings of the National Academy of Sciences Transcriptional RegulationSystems BiologyPrune2 ExpressionEngineeringMedicine	2015	270
Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas Brian J. Sworder, David M. Kurtz, Stefan Alig, Cancer Cell Lymphoid NeoplasiaCancer ImmunosurveillanceMedicineImmunologyAutoimmunity	2022	119
Early cytopenias and infections after standard of care idecabtagene vicleucel in relapsed or refractory multiple myeloma Jennifer M. Logue, Lauren C. Peres, Hamza Hashmi, Blood Advances	2022	94
Safety and efficacy of standard-of-care ciltacabtagene autoleucel for relapsed/refractory multiple myeloma Surbhi Sidana, Krina K. Patel, Lauren C. Peres, Blood	2024	92
Integrated nanotechnology platform for tumor-targeted multimodal imaging and therapeutic cargo release Hitomi Hosoya, Andrey S. Dobroff, Wouter H. P. Driessen, Proceedings of the National Academy of Sciences	2016	67
CD13-positive bone marrow-derived myeloid cells promote angiogenesis, tumor growth, and metastasis Eleonora Dondossola, Roberto Rangel, Liliana Guzman‐Rojas, Proceedings of the National Academy of Sciences	2013	54
Combinatorial targeting and discovery of ligand-receptors in organelles of mammalian cells Roberto Rangel, Liliana Guzman‐Rojas, Lucia Le Roux, Nature Communications	2012	46
Self-targeting of TNF-releasing cancer cells in preclinical models of primary and metastatic tumors Eleonora Dondossola, Andrey S. Dobroff, Serena Marchiò, Proceedings of the National Academy of Sciences Tnf-expressing Tumor CellsCancer ImmunosurveillanceMetastatic TumorsPreclinical ModelsMedicine	2016	45
Engineering fibrotic tissue in pancreatic cancer: A novel three-dimensional model to investigate nanoparticle delivery Hitomi Hosoya, Koji Kadowaki, Michiya Matsusaki, Biochemical and Biophysical Research Communications Tissue EngineeringNanoparticlesEngineeringPancreatic CancerNanoparticle Delivery	2012	43
Idecabtagene vicleucel chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma with renal impairment Surbhi Sidana, Lauren C. Peres, Hamza Hashmi, Haematologica	2023	36

Page 1